Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events: Lipoproteins and Coronary Atherosclerosis Study
- 30 June 1999
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 144 (2) , 435-442
- https://doi.org/10.1016/s0021-9150(99)00004-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.Journal of Clinical Investigation, 1997
- THE GENETICIST'S APPROACH TO COMPLEX DISEASEAnnual Review of Medicine, 1996
- A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosisNature Genetics, 1995
- Genetic and environmental effects on coronary heart disease risk factors in Northern Norway. The cardiovascular disease study in FinnmarkAnnals of Human Genetics, 1994
- Genetic Dissection of Complex TraitsScience, 1994
- DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatinThe American Journal of Cardiology, 1994
- Lipoprotein and hepatic lipase gene variants in coronary atherosclerosisAtherosclerosis, 1990
- Relation between family history of coronary artery disease and coronary risk variablesThe American Journal of Cardiology, 1988
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985